D van der Harst

Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones

D van der Harst, E Goulmy, JH Falkenburg et al. · Blood · 1994 · 151 citations · Full text

Life Sciences, Immunology, Oncology +16

Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.

J.H. Frederik Falkenburg, Henriëtte M. Goselink, D van der Harst et al. · The Journal of Experimental Medicine · 1991 · 132 citations · Full text

Life Sciences, Hematology, Immunology +17

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment.

Nir I. Weijl, D van der Harst, Anneke Brand et al. · Journal of Clinical Oncology · 1993 · 99 citations

Medicine, Endocrinology, Clinical Immunology +13

Clonal B-cell populations in patients with idiopathic thrombocytopenic purpura

D van der Harst, David De Jong, Jacqueline Limpens et al. · Blood · 1990 · 49 citations · Full text

Life Sciences, Hematology, Immunology +14

Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer- cell cytotoxicity [see comments]

JH Jansen, D van der Harst, G. J. H. M. Wientjens et al. · Blood · 1992 · 35 citations · Full text

Life Sciences, Immunology, Oncology +13